#United States #New York #Class Action #Securities Fraud #Hims & Hers Health

Class Action Alert: Hims & Hers Health, Inc. Investors

On August 8, 2025, Levi & Korsinsky, LLP announced a class action lawsuit concerning Hims & Hers Health, Inc. (stock symbol: HIMS). This lawsuit, which seeks to recover losses for investors negatively impacted by alleged securities fraud, covers the period from April 29, 2025, to June 23, 2025. Investors who may have been affected during this timeframe are encouraged to act quickly as the deadline to join the class action suit is August 25, 2025.

Case Background

The class action is driven by claims that Hims & Hers Health, Inc. engaged in misleading practices that compromised investor trust and safety. Specifically, the lawsuit alleges that the company was involved in the deceptive marketing and selling of questionable versions of the popular weight-loss drug Wegovy®, thus putting patient safety at risk. This situation raised concerns regarding Hims & Hers' collaboration with pharmaceutical giant Novo Nordisk, which could potentially face termination based on these allegations.

As outlined in the complaint, Hims & Hers reportedly made several false statements or concealed crucial information from investors about their business operations, leading to materially misleading claims about the company's financial and operational health. As a result, the lawsuit underscores the broader implications for investors relying on the company's positive statements about its future prospects.

Importance of Joining the Class Action

For those who have incurred financial losses related to their investments in Hims & Hers Health, the class action lawsuit is an important avenue for seeking potential compensation. Notably, participating in the lawsuit does not require individuals to serve as lead plaintiffs, allowing members of the class to share in any recovery without upfront costs or fees. This provides a significant opportunity for individuals to recover losses without incurring additional financial burden.

Next Steps for Investors

If you are an investor in Hims & Hers Health, Inc. and suffered a financial loss during the specified period, it is crucial to act before the August 25 deadline. Investors are advised to reach out to Levi & Korsinsky’s legal team for more information or assistance in filing claims. Interested parties can submit their information through the firm’s dedicated link here.

You can also contact Joseph E. Levi, Esq. directly to discuss your situation via email at [email protected] or by calling (212) 363-7500.

Why Choose Levi & Korsinsky?

Levi & Korsinsky boasts a formidable track record in securities litigation, having successfully recovered hundreds of millions of dollars for aggrieved shareholders over two decades. The firm's extensive experience in dealing with complex legal cases and partnerships with skilled legal professionals positions them as a premier choice for investors seeking recourse in similar situations.

With over 70 dedicated staff members, Levi & Korsinsky continues to be ranked among the top securities litigation firms in the United States. They have demonstrated their commitment to investor rights and welfare, making them an adept ally in navigating the complexities surrounding securities fraud claims.

Conclusion

The choice to participate in the Hims & Hers Health class action lawsuit could be life-altering for many investors. Given the pressing deadline of August 25, 2025, it is paramount that holders of Hims & Hers shares assess their situation and consider joining the legal action to uphold their rights and recover potential losses. Don't miss this opportunity to seek justice and accountability for your investments.